This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2014
  • /
  • 08
  • /
  • Avastin is FDA approved to treat Cervical Cancer -...
Drug news

Avastin is FDA approved to treat Cervical Cancer - Genentech/Roche

Read time: 1 mins
Last updated:16th Aug 2014
Published:16th Aug 2014
Source: Pharmawand

Genentech/Roche has announced that the FDA approved Avastin (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent or metastatic Carcinoma of the Cervix. With this approval in advanced Cervical Cancer, Avastin is approved in the United States to treat five distinct tumor types. The approval in advanced Cervical Cancer was based on the GOG-0240 study. Avastin is the first drug approved for patients with late-stage Cervical Cancer since the 2006 approval of topotecan with cisplatin.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.